![]() ![]() How to Invest in Farmland: 7 Simple Ways.Best Bank Stocks to Invest in Ahead of Rising Interest Rates.Array Technologies Brings Solar Flare To 2023 Earnings Forecast.How to Invest in the Top Grocery Stocks for This Year.MarketBeat Week in Review – 4/24 – 4/28.Get a free copy of the research report on ProPhase Labs (PRPH).It operates through the Diagnostic Services and Consumer Products segment. ProPhase Labs, Inc is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. will post -0.47 earnings per share for the current fiscal year. Analysts forecast that ProPhase Labs, Inc. ProPhase Labs had a net margin of 15.06% and a return on equity of 27.75%. The firm had revenue of $21.82 million during the quarter, compared to analyst estimates of $20.53 million. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.10). ProPhase Labs ( NASDAQ:PRPH – Get Rating) last issued its earnings results on Tuesday, March 28th. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.54 and a current ratio of 3.78. has a 1 year low of $6.31 and a 1 year high of $15.25. The stock has a market capitalization of $128.85 million, a PE ratio of 7.08 and a beta of -0.30. The company’s 50-day simple moving average is $7.72 and its 200-day simple moving average is $9.12. Shares of PRPH opened at $7.50 on Monday. Hedge funds and other institutional investors own 9.75% of the company’s stock. Ritholtz Wealth Management now owns 26,044 shares of the company’s stock worth $251,000 after buying an additional 5,368 shares during the period. Finally, Ritholtz Wealth Management boosted its stake in ProPhase Labs by 26.0% during the fourth quarter. purchased a new position in ProPhase Labs during the second quarter worth about $164,000. Cubist Systematic Strategies LLC purchased a new position in ProPhase Labs during the second quarter worth about $194,000. State Street Corp now owns 31,063 shares of the company’s stock worth $217,000 after buying an additional 3,868 shares during the period. State Street Corp boosted its stake in ProPhase Labs by 14.2% during the first quarter. Dimensional Fund Advisors LP now owns 24,841 shares of the company’s stock valued at $280,000 after purchasing an additional 1,820 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of ProPhase Labs by 7.9% in the third quarter. ![]() Other hedge funds have also recently modified their holdings of the company. Bank of Montreal Can owned 0.42% of ProPhase Labs at the end of the most recent quarter. The institutional investor acquired 67,900 shares of the company’s stock, valued at approximately $671,000. ( NASDAQ:PRPH – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). Bank of Montreal Can acquired a new stake in ProPhase Labs, Inc.
0 Comments
Leave a Reply. |